Park Vale Capital

Summary

The fund was located in Europe if to be more exact in United Kingdom. The main office of represented VC is situated in the London.

Among the various public portfolio startups of the fund, we may underline Cullinan Oncology, Cullinan Oncology, Causemo Moreover, a startup needs to be at the age of 2-3 years to get the investment from the fund. The fund has exact preference in some founders of portfolio startups. Among the most successful fund investment fields, there are CleanTech, Biopharma. For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States.

Comparing to the other companies, this Park Vale Capital performs on 4 percentage points more the average number of lead investments. The fund is constantly included in less than 2 investment rounds annually. The real fund results show that this VC is 13 percentage points more often commits exit comparing to other companies. The usual things for fund are deals in the range of 50 - 100 millions dollars. The important activity for fund was in 2017. The increased amount of exits for fund were in 2019.

The standard case for the fund is to invest in rounds with 3-4 partakers. Despite the Park Vale Capital, startups are often financed by MPM Capital, F2 Ventures. The meaningful sponsors for the fund in investment in the same round are MPM Capital, F2 Ventures, SessionM. In the next rounds fund is usually obtained by MPM Capital, F2 Ventures.